Long-term efficacy of biologics in moderate-to-severe hidradenitis suppurativa: A systematic review and MAIC
{{output}}
Background: There is a lack of direct comparative studies evaluating the long-term efficacy of the approved biologic therapies bimekizumab, secukinumab and adalimumab for moderate-to-severe hidradenitis suppurativa (HS) beyond We... ...
